SlideShare a Scribd company logo
1 of 39
Healthcare Analytics:
Mining Electronic Medical Records
Leslie McIntosh, PhD, MPH
Health Informatics
Computer Science/IS
Health/MedicineAnalytics/Statistics
https://edgewatertech.wordpress.com
Located, Consolidated, and
Standardized the Data
Facilities
Syntactic interoperability
Use of standardized programming interfaces
 APIs
 Service-oriented architecture
 Messaging standards
Semantic interoperability
Use of controlled vocabularies and ontologies
 ICD9-10 – Diagnosis Codes
 LOINC – Laboratory tests
 SNOMED – Clinical terms (e.g. diagnoses)
 CPT – Medical procedures
 RxNORM – Medications
Facilitating Interoperability
Clinical Data
Demographics : name, address, race, gender, phone number
Visits: age, patient type, facility, diagnosis code, procedure code
Labs: age, collection time, facility, lab procedure, lab test name,
specimen type (e.g. serum vs CSF glucose), result
Medications: age, duration, frequency, medication, route & form
Allergies: allergen type, allergy reaction, sensitivity, severity, type, onset
date
Vitals: age, body site, facility, measurement, observation, value and units
Documents: age, document content, document name, facility and
physician
Illicit Drug Use: type, history, positive/negative
Biospecimen Data: Specimen Type, Accession Number and Clinical
diagnosis
Natural Language Processing (NLP)
Custom Analytics
Acknowledgements
• Leslie D. McIntosh, PhD, MPH – Washington University
• Walton Sumner, MD – Washington University
• Lynn Latham - BJC
• Bijoy George – Washington University
• Pavan Kalantri – Washington University
• Suhas Khot – Washington University
• Anthony Juehne – Washington University
• Rakesh Nagarajan MD, PhD – Washington University
Alcohol, Tobacco, and Illicit Drug Use in
Patients are Not Discrete Data
Problem
Electronic Medical Documents
Rules Creation
Alcohol
Tobacco
Illicit Drugs
CIDER
Mining Discrete Data
Chronic Diseases associated with
Multiple CTs
Unknown what Diagnoses are
Associated with Multiple CT Scans
Problem #1
Common Chronic Diseases
Problem #2
Acknowledgements
• Richard Griffey, MD, Division of Emergency Medicine, Washington
University School of Medicine
• Leslie McIntosh, PhD, MPH, Center for Biomedical Informatics,
Department of Pathology, Washington University School of Medicine
• Tom Bailey, MD, Division of Infectious Diseases, Department of Medicine,
Washington University School of Medicine
Disclosure
• Emergency Medicine Foundation & Emergency Medicine Patient Safety
Foundation Patient Safety Fellowship
• Institutional KM1 Comparative Effectiveness Award Number
KM1CA156708 through the National Cancer Institute (NCI) at the National
Institutes of Health (NIH) and Grant Numbers UL1 RR024992, KL2
RR024994, TL1 RR024995 through The Clinical and Translational Science
Award (CTSA) program of the National Center for Research Resources and
the National Center for Advancing Translational Sciences at the National
Institutes of Health.
Background
Methods
Design: Exploratory, Retrospective
Step 1
Identify conditions among patients associated with
being in the top 10% of CT study count
Step 2
Test whether among all patients having one of
these conditions increased the odds of being highly
imaged (in the top 10%).
Patients with 5+ CT
(2004-2011)
Prior CT at BJH*
(2004-2011)
Unique patients
BJH - ED (2011)
58,079
35,3982 (0)
21,404 (1+ with Dx)
693 (1+ w/o Dx)
18,816 (no) 2,588 (yes)
1. Identify patients in top 10% of CT
ED Visit + CT (ever)
*CTs were limited to those commonly ordered from the ED
(e.g. head, cervical spine, chest, abdomen-pelvis)
2. Identify diagnoses (ICD-9s) associated with these visits*
• Rank by frequency & dual review those appearing >100 times
• Statistical scoring (based on NLP algorithm tf-idf)
• Exclude: cancer diagnoses, non-chronic conditions (e.g.
trauma), those not mapping to an indication for imaging (e.g.
HTN, DM)
1830 malignant neoplasm of ovary
7533 other specified congenital anomalies of kidney
5308 other specified disorders of esophagus
5678 other specified peritonitis
75313 polycystic kidney autosomal dominant
2384 polycythemia vera
7530 renal agenesis and dysgenesis
5582 toxic gastroenteritis and colitis
1551 malignant neoplasm of intrahepatic bile ducts
20210 mycosis fungoides unspecified site
4413 abdomial aortic aneurysm ruptured
1520 malignant neoplasm of duodenum
1541 malignant neoplasm of rectum
53087 mechanical complication of esophagostomy
56489 other functional disorders of intestine
19882 secondary malignant neoplasm of genital organs
4412 thoracic aortic aneurysm without mention of rupture
5187 transfusion related acute lung injury
6190 urinary-genital tract fistula female
99681 complications of transplanted kidney
* Inpatient & ED only
Candidate diagnoses
112.5 partial complex seizure
282.6 Sickle cell disease
115.1 schizophrenia
774.0 psychosis
979.7 petite mal seizure
532.4 pulmonary embolus
487.3 quadriplegia
475.8 hemiparesis
784.9 HIV
282.3 Hb-ss disease without crisis
232.0 ulcerative colitis
215.1 lupus
212.3 sickle cell NOS
343.5 migraine
489.6 constipation
234.1 crohn’s disease
299.5 hydrocephalus
214.1 sickle cell pain crisis
HCUP Clinical Classification System
Sickle cell disease
282.3 348.6 594.7 843.6 119.0
298.4 120.9 879.4 282.3 948.1
387.3 282.6 859.1 214.1 902.0
893.0 213.3 912.1 981.1 873.0
Paralysis
349.4 348.6 594.7 843.6 432.4
475.8 120.9 879.4 239.5 948.1
387.3 212.3 859.1 203.1 902.0
893.0 487.3 912.1 981.1 873.0
Regional enteritis
349.4 348.6 594.7 843.6 234.1
298.4 120.9 879.4 239.5 948.1
387.3 212.3 859.1 203.1 902.0
232.0 213.3 912.1 981.1 873.0
Psychosis
349.4 348.6 594.7 843.6 432.4
298.4 120.9 879.4 239.5 948.1
387.3 290.3 859.1 203.1 902.0
893.0 249.3 912.1 115.1 873.0
3. Cluster similar diagnoses in to “conditions”
214.1
282.3
213.3
94
532
1137
6,331
Diagnoses
94 21
Methods – Step 2
CT Status
Diagnosis
of Interest
Patients at
BJH (years
in system)
Patients at
BJH(2010)
230,531
102,141
(2+)
23,382 (y)
5,972
(5+)
19,817
(0-4)
78,759 (n)
3,565
(5+)
72,787
(0-4)
128,390
(<2)
Big Data Consumable
Built a Tool
Trained Clinicians
{This page intentionally left blank}
People
Computer Scientists/Developers
Analysts
Clinical Researchers
In the end, we have…
Developers
Analysts
Clinicians
DATA
Data Drivers
Liaisons facilitating the
transformation of data to
information to knowledge
What’s next

More Related Content

What's hot

Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...
Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...
Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...Ahmad Ozair
 
Hepatocellular carcinoma premanagement
Hepatocellular carcinoma premanagementHepatocellular carcinoma premanagement
Hepatocellular carcinoma premanagementManish Dutt
 
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Factors associated with developing esophageal adenocarcinoma in Barett's esop...Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Factors associated with developing esophageal adenocarcinoma in Barett's esop...Dr Sayan Das
 
The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...
The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...
The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...Mina Max
 
Meningitis
MeningitisMeningitis
Meningitisusapuka
 
Hysterectomy for benign conditions in a university hospital in2
Hysterectomy for benign conditions in a university hospital in2Hysterectomy for benign conditions in a university hospital in2
Hysterectomy for benign conditions in a university hospital in2Tariq Mohammed
 
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...Dr Tarique Ahmed Maka
 
Francesco Procaccio - Italy - Tuesday 29 - Donor Risk
Francesco Procaccio - Italy - Tuesday 29 - Donor RiskFrancesco Procaccio - Italy - Tuesday 29 - Donor Risk
Francesco Procaccio - Italy - Tuesday 29 - Donor Riskincucai_isodp
 
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015José Antonio García Erce
 
Diagnostic Efficacy of Ultra-High-Field MRS in Glioma Patients
Diagnostic Efficacy of Ultra-High-Field MRS in Glioma PatientsDiagnostic Efficacy of Ultra-High-Field MRS in Glioma Patients
Diagnostic Efficacy of Ultra-High-Field MRS in Glioma PatientsUzay Emir
 
Estimation of Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL MICR...
Estimation of Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL MICR...Estimation of Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL MICR...
Estimation of Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL MICR...dr.Ihsan alsaimary
 

What's hot (20)

Herramientas de Análisis de Comorbilidades en la HCE (SummerSchool UB)
Herramientas de Análisis de Comorbilidades en la HCE (SummerSchool UB)Herramientas de Análisis de Comorbilidades en la HCE (SummerSchool UB)
Herramientas de Análisis de Comorbilidades en la HCE (SummerSchool UB)
 
Cluj
ClujCluj
Cluj
 
Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...
Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...
Letter: Is the Stupp Protocol an expensive and unsustainable standard of care...
 
Hepatocellular carcinoma premanagement
Hepatocellular carcinoma premanagementHepatocellular carcinoma premanagement
Hepatocellular carcinoma premanagement
 
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Factors associated with developing esophageal adenocarcinoma in Barett's esop...Factors associated with developing esophageal adenocarcinoma in Barett's esop...
Factors associated with developing esophageal adenocarcinoma in Barett's esop...
 
Gabric ID - AIMRADIAL 2013 - Radial in STEMI
Gabric ID - AIMRADIAL 2013 - Radial in STEMIGabric ID - AIMRADIAL 2013 - Radial in STEMI
Gabric ID - AIMRADIAL 2013 - Radial in STEMI
 
The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...
The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...
The CIBMTR score predicts survival of AML patients undergoing allogeneic tran...
 
Factors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resectionFactors Predict Perioperative Morbidity pancreatic resection
Factors Predict Perioperative Morbidity pancreatic resection
 
14 ijcse-01234
14 ijcse-0123414 ijcse-01234
14 ijcse-01234
 
H046043046
H046043046H046043046
H046043046
 
Meningitis
MeningitisMeningitis
Meningitis
 
Hysterectomy for benign conditions in a university hospital in2
Hysterectomy for benign conditions in a university hospital in2Hysterectomy for benign conditions in a university hospital in2
Hysterectomy for benign conditions in a university hospital in2
 
مجلة توفيقTJMS
مجلة توفيقTJMSمجلة توفيقTJMS
مجلة توفيقTJMS
 
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
frequency of hepatitis C virus infection in patients with type 2 diabetes mel...
 
Francesco Procaccio - Italy - Tuesday 29 - Donor Risk
Francesco Procaccio - Italy - Tuesday 29 - Donor RiskFrancesco Procaccio - Italy - Tuesday 29 - Donor Risk
Francesco Procaccio - Italy - Tuesday 29 - Donor Risk
 
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr García Erce. Roma 2015
 
Mamas M - AIMRADIAL 2015 - Access vs. non-access site bleeding
Mamas M - AIMRADIAL 2015 - Access vs. non-access site bleedingMamas M - AIMRADIAL 2015 - Access vs. non-access site bleeding
Mamas M - AIMRADIAL 2015 - Access vs. non-access site bleeding
 
Diagnostic Efficacy of Ultra-High-Field MRS in Glioma Patients
Diagnostic Efficacy of Ultra-High-Field MRS in Glioma PatientsDiagnostic Efficacy of Ultra-High-Field MRS in Glioma Patients
Diagnostic Efficacy of Ultra-High-Field MRS in Glioma Patients
 
Estimation of Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL MICR...
Estimation of Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL MICR...Estimation of Dr. ihsan edan abdulkareem alsaimary  PROFESSOR IN MEDICAL MICR...
Estimation of Dr. ihsan edan abdulkareem alsaimary PROFESSOR IN MEDICAL MICR...
 
Final FRD
Final FRDFinal FRD
Final FRD
 

Similar to TDWI STL 20140306 Analytics - Leslie McIntosh

Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...
Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...
Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...hivlifeinfo
 
Using real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsUsing real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsKarin Verspoor
 
Maximising the value of routine NHS Data - Innovation Show
Maximising the value of routine NHS Data - Innovation ShowMaximising the value of routine NHS Data - Innovation Show
Maximising the value of routine NHS Data - Innovation ShowInnovation Agency
 
Kidney Disease In patients living with HIV
Kidney Disease In patients living with HIVKidney Disease In patients living with HIV
Kidney Disease In patients living with HIVChristos Argyropoulos
 
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docxn engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docxrosemarybdodson23141
 
US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...
US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...
US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...ReportsnReports
 
Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...ReportsnReports
 
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...Fundación Ramón Areces
 
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...National Alopecia Areata Foundation
 
Mark Caulfield (Genomics England) - Understanding how genomics will transform...
Mark Caulfield (Genomics England) - Understanding how genomics will transform...Mark Caulfield (Genomics England) - Understanding how genomics will transform...
Mark Caulfield (Genomics England) - Understanding how genomics will transform...NHShcs
 
France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...
France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...
France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...ReportsnReports
 
Hepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseasesHepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseasesSamir Haffar
 
Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...ReportsnReports
 
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...ReportsnReports
 
New thesis protocol presentation.pptx
New thesis protocol presentation.pptxNew thesis protocol presentation.pptx
New thesis protocol presentation.pptxCutiePie71
 
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...UC San Diego AntiViral Research Center
 
synopsis.pptx
synopsis.pptxsynopsis.pptx
synopsis.pptxdiganthcd
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011Phil Boehmer
 

Similar to TDWI STL 20140306 Analytics - Leslie McIntosh (20)

Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...
Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...
Современное лечение ВИЧ : лечение возрастных пациентов.2017/Contemporary Mana...
 
Using real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questionsUsing real-world evidence to investigate clinical research questions
Using real-world evidence to investigate clinical research questions
 
Maximising the value of routine NHS Data - Innovation Show
Maximising the value of routine NHS Data - Innovation ShowMaximising the value of routine NHS Data - Innovation Show
Maximising the value of routine NHS Data - Innovation Show
 
Kidney Disease In patients living with HIV
Kidney Disease In patients living with HIVKidney Disease In patients living with HIV
Kidney Disease In patients living with HIV
 
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docxn engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
n engl j med 368;24 nejm.org june 13, 2013 2319s o u n d i.docx
 
US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...
US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...
US Molecular Diagnostics Market: Innovative Technologies and Emerging Busines...
 
Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Italy Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
 
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
Ségolème Aymé - Infraestructuras de I + D para impulsar investigación en Enfe...
 
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
Comorbidities Present in the Alopecia Areata Registry, Biobank & Clinical Tri...
 
South Africa Health Science Research
South Africa Health Science ResearchSouth Africa Health Science Research
South Africa Health Science Research
 
Mark Caulfield (Genomics England) - Understanding how genomics will transform...
Mark Caulfield (Genomics England) - Understanding how genomics will transform...Mark Caulfield (Genomics England) - Understanding how genomics will transform...
Mark Caulfield (Genomics England) - Understanding how genomics will transform...
 
The State of Play in Diagnosis
The State of Play in DiagnosisThe State of Play in Diagnosis
The State of Play in Diagnosis
 
France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...
France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...
France Molecular Diagnostics Market: Innovative Technologies and Emerging Bus...
 
Hepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseasesHepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseases
 
Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Japan Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
 
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Busi...
 
New thesis protocol presentation.pptx
New thesis protocol presentation.pptxNew thesis protocol presentation.pptx
New thesis protocol presentation.pptx
 
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
The State of the Art in HIV Cure Research – Hope or Hype: What Does It Mean f...
 
synopsis.pptx
synopsis.pptxsynopsis.pptx
synopsis.pptx
 
Start impaact june 7 2011
Start impaact june 7 2011Start impaact june 7 2011
Start impaact june 7 2011
 

Recently uploaded

Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxhariprasad279825
 
Take control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteTake control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteDianaGray10
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Commit University
 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.Curtis Poe
 
Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLScyllaDB
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Mattias Andersson
 
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DayH2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DaySri Ambati
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
 
TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024Lonnie McRorey
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):comworks
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsSergiu Bodiu
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc
 

Recently uploaded (20)

Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Artificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptxArtificial intelligence in cctv survelliance.pptx
Artificial intelligence in cctv survelliance.pptx
 
Take control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test SuiteTake control of your SAP testing with UiPath Test Suite
Take control of your SAP testing with UiPath Test Suite
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!
 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.
 
Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQL
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?
 
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo DayH2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
H2O.ai CEO/Founder: Sri Ambati Keynote at Wells Fargo Day
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
 
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
 
TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024TeamStation AI System Report LATAM IT Salaries 2024
TeamStation AI System Report LATAM IT Salaries 2024
 
CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):CloudStudio User manual (basic edition):
CloudStudio User manual (basic edition):
 
DevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platformsDevEX - reference for building teams, processes, and platforms
DevEX - reference for building teams, processes, and platforms
 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
 

TDWI STL 20140306 Analytics - Leslie McIntosh

  • 1. Healthcare Analytics: Mining Electronic Medical Records Leslie McIntosh, PhD, MPH
  • 2.
  • 5.
  • 6.
  • 9. Syntactic interoperability Use of standardized programming interfaces  APIs  Service-oriented architecture  Messaging standards Semantic interoperability Use of controlled vocabularies and ontologies  ICD9-10 – Diagnosis Codes  LOINC – Laboratory tests  SNOMED – Clinical terms (e.g. diagnoses)  CPT – Medical procedures  RxNORM – Medications Facilitating Interoperability
  • 10. Clinical Data Demographics : name, address, race, gender, phone number Visits: age, patient type, facility, diagnosis code, procedure code Labs: age, collection time, facility, lab procedure, lab test name, specimen type (e.g. serum vs CSF glucose), result Medications: age, duration, frequency, medication, route & form Allergies: allergen type, allergy reaction, sensitivity, severity, type, onset date Vitals: age, body site, facility, measurement, observation, value and units Documents: age, document content, document name, facility and physician Illicit Drug Use: type, history, positive/negative Biospecimen Data: Specimen Type, Accession Number and Clinical diagnosis
  • 11. Natural Language Processing (NLP) Custom Analytics
  • 12. Acknowledgements • Leslie D. McIntosh, PhD, MPH – Washington University • Walton Sumner, MD – Washington University • Lynn Latham - BJC • Bijoy George – Washington University • Pavan Kalantri – Washington University • Suhas Khot – Washington University • Anthony Juehne – Washington University • Rakesh Nagarajan MD, PhD – Washington University
  • 13. Alcohol, Tobacco, and Illicit Drug Use in Patients are Not Discrete Data Problem
  • 16. CIDER
  • 17. Mining Discrete Data Chronic Diseases associated with Multiple CTs
  • 18. Unknown what Diagnoses are Associated with Multiple CT Scans Problem #1
  • 20. Acknowledgements • Richard Griffey, MD, Division of Emergency Medicine, Washington University School of Medicine • Leslie McIntosh, PhD, MPH, Center for Biomedical Informatics, Department of Pathology, Washington University School of Medicine • Tom Bailey, MD, Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine
  • 21. Disclosure • Emergency Medicine Foundation & Emergency Medicine Patient Safety Foundation Patient Safety Fellowship • Institutional KM1 Comparative Effectiveness Award Number KM1CA156708 through the National Cancer Institute (NCI) at the National Institutes of Health (NIH) and Grant Numbers UL1 RR024992, KL2 RR024994, TL1 RR024995 through The Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources and the National Center for Advancing Translational Sciences at the National Institutes of Health.
  • 23. Methods Design: Exploratory, Retrospective Step 1 Identify conditions among patients associated with being in the top 10% of CT study count Step 2 Test whether among all patients having one of these conditions increased the odds of being highly imaged (in the top 10%).
  • 24. Patients with 5+ CT (2004-2011) Prior CT at BJH* (2004-2011) Unique patients BJH - ED (2011) 58,079 35,3982 (0) 21,404 (1+ with Dx) 693 (1+ w/o Dx) 18,816 (no) 2,588 (yes) 1. Identify patients in top 10% of CT ED Visit + CT (ever) *CTs were limited to those commonly ordered from the ED (e.g. head, cervical spine, chest, abdomen-pelvis)
  • 25. 2. Identify diagnoses (ICD-9s) associated with these visits* • Rank by frequency & dual review those appearing >100 times • Statistical scoring (based on NLP algorithm tf-idf) • Exclude: cancer diagnoses, non-chronic conditions (e.g. trauma), those not mapping to an indication for imaging (e.g. HTN, DM) 1830 malignant neoplasm of ovary 7533 other specified congenital anomalies of kidney 5308 other specified disorders of esophagus 5678 other specified peritonitis 75313 polycystic kidney autosomal dominant 2384 polycythemia vera 7530 renal agenesis and dysgenesis 5582 toxic gastroenteritis and colitis 1551 malignant neoplasm of intrahepatic bile ducts 20210 mycosis fungoides unspecified site 4413 abdomial aortic aneurysm ruptured 1520 malignant neoplasm of duodenum 1541 malignant neoplasm of rectum 53087 mechanical complication of esophagostomy 56489 other functional disorders of intestine 19882 secondary malignant neoplasm of genital organs 4412 thoracic aortic aneurysm without mention of rupture 5187 transfusion related acute lung injury 6190 urinary-genital tract fistula female 99681 complications of transplanted kidney * Inpatient & ED only
  • 26. Candidate diagnoses 112.5 partial complex seizure 282.6 Sickle cell disease 115.1 schizophrenia 774.0 psychosis 979.7 petite mal seizure 532.4 pulmonary embolus 487.3 quadriplegia 475.8 hemiparesis 784.9 HIV 282.3 Hb-ss disease without crisis 232.0 ulcerative colitis 215.1 lupus 212.3 sickle cell NOS 343.5 migraine 489.6 constipation 234.1 crohn’s disease 299.5 hydrocephalus 214.1 sickle cell pain crisis HCUP Clinical Classification System Sickle cell disease 282.3 348.6 594.7 843.6 119.0 298.4 120.9 879.4 282.3 948.1 387.3 282.6 859.1 214.1 902.0 893.0 213.3 912.1 981.1 873.0 Paralysis 349.4 348.6 594.7 843.6 432.4 475.8 120.9 879.4 239.5 948.1 387.3 212.3 859.1 203.1 902.0 893.0 487.3 912.1 981.1 873.0 Regional enteritis 349.4 348.6 594.7 843.6 234.1 298.4 120.9 879.4 239.5 948.1 387.3 212.3 859.1 203.1 902.0 232.0 213.3 912.1 981.1 873.0 Psychosis 349.4 348.6 594.7 843.6 432.4 298.4 120.9 879.4 239.5 948.1 387.3 290.3 859.1 203.1 902.0 893.0 249.3 912.1 115.1 873.0 3. Cluster similar diagnoses in to “conditions” 214.1 282.3 213.3
  • 28. Methods – Step 2 CT Status Diagnosis of Interest Patients at BJH (years in system) Patients at BJH(2010) 230,531 102,141 (2+) 23,382 (y) 5,972 (5+) 19,817 (0-4) 78,759 (n) 3,565 (5+) 72,787 (0-4) 128,390 (<2)
  • 30. Built a Tool Trained Clinicians
  • 36. In the end, we have… Developers Analysts Clinicians
  • 37. DATA
  • 38. Data Drivers Liaisons facilitating the transformation of data to information to knowledge